Clinical Trial

Use of Hydrogen Sulphide Donor (N-acetyl Cysteine) in Cases With Acute Ischemic Stroke

Name: Use of Hydrogen Sulphide Donor (N-acetyl Cysteine) in Cases With Acute Ischemic Stroke — clinical trial record (NCT07749287)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: NAC - H2S

Completed Phase 3

View on ClinicalTrials.gov →

Summary

1. Clarify novel systemic and local inflammatory mechanisms underlying the cross talk between brain and heart ischemic states, 2. Investigate the new aspects of NAC beyond traditional therapy, in cerebral and myocardial ischemic conditions, both in animal models and clinical cases.

Trial Details

NCT Number	NCT07749287
Lead Sponsor	Helwan University
Conditions	Ischemic Cerebral Infarction
Enrollment	121 participants
Start Date	2021-06-01
Primary Completion	2023-01-01 (estimated)
Study Completion	2024-03-01 (estimated)
Updated on ClinicalTrials.gov	2026-08-06